
Sabra Health Care REIT, Inc. (SBRA)
$
20.55
-0.31 (-1.51%)
Key metrics
Financial statements
Free cash flow per share
1.3979
Market cap
5.2 Billion
Price to sales ratio
6.6891
Debt to equity
0.4455
Current ratio
0.1454
Income quality
2.2406
Average inventory
0
ROE
0.0563
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
As of March 31, 2022, Sabra's investment portfolio featured 416 real estate properties held for investment, which incorporated a variety of facilities, including 279 Skilled Nursing/Transitional Care facilities, 59 Senior Housing communities categorized as Senior Housing - Leased, and 50 other Senior Housing communities managed by third-party property managers under property management agreements classified as Senior Housing - Managed. Additionally, the portfolio consisted of 13 Behavioral Health facilities and 15 Specialty Hospitals and other facilities. The cost of revenue for the company is $271,106,000.00 showcasing its production and operational expenses, while the gross profit stands at $503,526,000.00 highlighting the company's profitability from core operations. Furthermore, the company incurred an income tax expense of $1,837,000.00 indicating its tax obligations. The total costs and expenses for the company are $510,765,000.00 reflecting its overall spending. In the realm of financial investments, the company earned an interest income of $0.00 showcasing its strategic ventures. Sabra's real estate properties held for investment included a total of 41,445 beds/units, distributed across the United States and Canada. Moving on to the stock performance, it is currently considered affordable at $18.71 making it suitable for budget-conscious investors. The stock has a high average trading volume of 2,873,986.00 indicating strong liquidity in the market. With a mid-range market capitalization of $5,181,594,484.00 the company stands out as a steady performer in its sector. It is a key player in the REIT - Healthcare Facilities industry, contributing significantly to the overall market landscape and driving innovation and growth within the Real Estate sector. The combination of affordability, liquidity, and strategic positioning of the company underscores its potential as an attractive investment option for various investors.
Investing in Sabra Health Care REIT, Inc. (SBRA) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as B+, with a Bullish outlook. Always conduct your own research before investing.
Analysts predict Sabra Health Care REIT, Inc. stock to fluctuate between $15.75 (low) and $21.07 (high) in the next 365 days, reflecting market expectations and potential volatility.
As of 2026-02-27, Sabra Health Care REIT, Inc.'s market cap is $5,181,594,484, based on 252,145,717 outstanding shares.
Compared to PROLOGIS, INC., Sabra Health Care REIT, Inc. has a Lower Market-Cap, indicating a difference in performance.
Sabra Health Care REIT, Inc. pays dividends. The current dividend yield is 5.95%, with a payout of $0.30 per share.
To buy Sabra Health Care REIT, Inc. (SBRA) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for SBRA. Place an order (Market, Limit, etc.).
The best time to invest depends on market trends and technical indicators, which show a Bullish trend based on economic conditions and company performance.
Sabra Health Care REIT, Inc.'s last stock split was 1:3 on 2010-11-16.
Revenue: $774,632,000 | EPS: $0.64 | Growth: 18.52%.
Visit https://www.sabrahealth.com/investor-relations for detailed financial reports.
You can explore historical data from here
All-time high: $21.07 (2026-02-27) | All-time low: $10.08 (2023-03-24).
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News

seekingalpha.com
Sabra Health Care REIT, Inc. (SBRA) Q4 2025 Earnings Call Transcript

businesswire.com
TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #2025tax--Sabra Health Care REIT, Inc. (NASDAQ: SBRA) announced today the tax treatment for its 2025 distributions. The following table summarizes, for income tax purposes, the nature of cash distributions paid: Sabra Health Care REIT, Inc. Common Stock (CUSIP # 78573L106) Record Date Payable Date Distribution per Share Total Ordinary Dividends Non-Qualified Dividends Qualified Dividends Non-Dividend Distributions 02/14/2025 02/28/2025 $ 0.3000000 $ 0.2438846 .

businesswire.com
TUSTIN, Calif.--(BUSINESS WIRE)---- $CIO #CIO--Sabra Health Care REIT, Inc. (“Sabra”) (Nasdaq: SBRA) today announced that Darrin Smith has been appointed Sabra's Chief Investment Officer, Secretary and Executive Vice President, effective January 1, 2026. Mr. Smith succeeds Talya Nevo-Hacohen, Sabra's former Chief Investment Officer, Treasurer and Executive Vice President in connection with her retirement on December 31, 2025. From March 2020 until his appointment as Chief Investment Officer, Mr. Smith served.

seekingalpha.com
My update on Sabra Health Care REIT upgrades it to a strong buy. Although technical indicators point to a hold, several fundamentals drive the needle into the highly bullish range, particularly portfolio growth and macro demand in this niche of senior care. AFFO dividend coverage is adequate, though the payout ratio is slightly elevated at around 81%.

seekingalpha.com
Sabra Health Care REIT presents a compelling value-income opportunity, offering a 6.4% yield and robust fundamentals. SBRA's SHOP segment drives growth, with same-store NOI up 13.3% and significant new investments targeting a 40% SHOP NOI mix. It received an investment-grade rating, has safe leverage, and has no debt maturities until 2027, supporting dividend safety.

seekingalpha.com
Sabra Health Care REIT, Inc. ( SBRA ) Q3 2025 Earnings Call November 6, 2025 1:00 PM EST Company Participants Lukas Hartwich - Executive Vice President of Finance Rick Matros - Chairman, President & CEO Talya Nevo-Hacohen - Executive VP, Chief Investment Officer & Treasurer Darrin Smith - Executive Vice President of Investments Michael Costa - Executive VP, CFO & Secretary Conference Call Participants Farrell Granath - BofA Securities, Research Division Austin Wurschmidt - KeyBanc Capital Markets Inc., Research Division William John Kilichowski - Wells Fargo Securities, LLC, Research Division Seth Bergey - Citigroup Inc., Research Division Juan Sanabria - BMO Capital Markets Equity Research Richard Anderson - Cantor Fitzgerald & Co., Research Division Alec Feygin - Robert W. Baird & Co. Incorporated, Research Division Michael Stroyeck - Green Street Advisors, LLC, Research Division Omotayo Okusanya - Deutsche Bank AG, Research Division Presentation Operator Good day, everyone.
businesswire.com
TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #BofA--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Darrin Smith, the company's Executive Vice President of Investments, Eliza Gozar, the company's Senior Vice President of Investments, Kara Pappanduros, the company's Senior Vice President of Asset Management, and other members of the company, will attend the 2025 NIC Fall Conference on September 8 – 10, 2025, at the JW Marriott Austin in Austin, Texas. Additionally, Rick Matros, the company's Chair.

prnewswire.com
BEND, Ore. , Aug. 20, 2025 /PRNewswire/ -- Sunshine Retirement Living, a leading provider of mid-market senior living communities in the United States, is expanding its national footprint through a new management agreement with Sabra Health Care REIT, Inc. (Nasdaq: SBRA). This agreement adds five independent living communities across four Western states, growing Sunshine Retirement Living's portfolio from 35 to 40 communities in 17 states.

seekingalpha.com
Sabra Health Care REIT, Inc. (NASDAQ:SBRA ) Q2 2025 Earnings Conference Call August 5, 2025 1:00 PM ET Company Participants Lukas Michael Hartwich - Executive Vice President of Finance Michael Lourenco Costa - Executive VP, CFO & Secretary Richard K. Matros - Chairman, President & CEO Talya Nevo-Hacohen - Executive VP, Chief Investment Officer & Treasurer Conference Call Participants Alec Gregory Feygin - Robert W.

zacks.com
Although the revenue and EPS for Sabra (SBRA) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
See all news